Marine Biotech Limited(MBL) is a biotechnology research company based in Stirling, Scotland. With a focus on research of marine species through sustainable aquaculture, MBL has already established its mandate with the American Horseshoe Crab.

Having successfully completed a two year commercial pilot MBL is now raising funds to launch a commercial facility for the production of Limulus Amebocyte Lysate (LAL) from a world first sustainable and farmed source.

With its commercial focus, MBL already has a range of new potential products under research and development.

MBL is now fundraising for its commercial operations and all enquiries can be directed to Alex Clarkson, Diagnostics Capital, "Alex.clarkson at diagnostic-capital.co.uk", 0161 359 3414.